January 20, 2022
With tuberculosis resurgent after two years of COVID-19-inspired neglect, TB Alliance is awarded USAID funding to develop new treatments
December 15, 2021
TaBriX and The University of Manchester are working with TB Alliance to develop novel drugs to treat drug-resistant tuberculosis
November 23, 2021
Advancing Clinical Research Capacity in Europe: Almari Conradie on TBAJ-587 and the ERA4TB Project
October 19, 2021
TB Alliance Welcomes New Data on BPaL-Based Regimens Presented at the 2021 Union Conference
October 14, 2021
WHO Global Tuberculosis Report—New Drugs and Regimens Need to be Combined with Equitable and Universal Access
Statement by Mel Spigelman, MD, President and Chief Executive Officer, TB Alliance
September 30, 2021
TB Alliance Welcomes New Board Members
Dr. Eric Goosby, Sundar Kodiyalam, David Y. Norton, and Sangita Reddy Join Board
September 6, 2021
TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB
August 19, 2021
TB Alliance Convenes Community Engagement Stakeholders to Discuss Clinical Trial Updates
During a virtual forum on August 12, 2021 speakers shared experiences and updates on engaging with communities for research and development programs
July 15, 2021